logo
CancerCare Manitoba hires new CEO

CancerCare Manitoba hires new CEO

CancerCare Manitoba will soon be under new leadership, the provincial agency's staff members learned Friday.
Dr. Kent Stobart has been hired to replace former president and CEO Dr. Sri Navaratnam, who left the role well before the end of her contract. Stobart worked at the facility from 1999 to 2002.
'We are excited to welcome Dr. Stobart back to CancerCare Manitoba,' a spokesperson told the Free Press Friday evening.
MIKE DEAL / FREE PRESS FILES
'A pediatric oncologist and accomplished academic leader, he brings a wealth of experience, deep knowledge of cancer care and a proven commitment to patients. These qualities will be instrumental in shaping CCMB's future. Given the rigorous and extensive search undertaken for this position, CancerCare Manitoba's board is confident that Dr. Stobart is the right leader to guide CCMB into its next era.'
The facility's staff learned of the hiring earlier Friday in a letter from board chair Jeoffrey Chipman.
'Our goal was to find a leader who not only brings exceptional experience but also aligns with the values that define our organization: collaboration, innovation, integrity and a deep commitment to patient care,' he wrote.
'We are confident Dr. Stobart has this experience, embodies these values and will help guide the strategic leadership of (CancerCare Manitoba).'
Stobart has been a doctor since 1984 and has held clinical and academic roles in all four western Canadian provinces. Most recently, he served as the vice-dean of education in the University of Saskatchewan's College of Medicine, Chipman's letter said.
Stobart will take the helm in November, 'once he has had the opportunity to orient himself in his new role,' it said.
Dr. Donna Turner will remain in place as the agency's interim leader during the transition. Turner was appointed to the role in April after Navaratnam announced she was leaving before her contract was set to expire in December.
MIKE DEAL / FREE PRESS FILES
Navaratnam had previously announced her intention not to renew her contract, leaving behind a leadership role she had held since 2014.
Professional services firm MNP was contracted to lead an international search for her replacement last November.
Chipman thanked Turner for her leadership over the past several months. She will return to her role as chief of population oncology once Stobart takes over, the letter said.
'Her steady leadership and unwavering dedication have been essential in maintaining the momentum of our work and the stability of our operations,' it said.
'The (CancerCare Manitoba) board also wants to thank all staff for their dedication and commitment during the past number of months. Your commitment to excellence and your continuing focus on providing the best care to Manitobans, is outstanding… We look forward to this next chapter for our organization.'
Doctors Manitoba, the organization representing physicians in the province, welcomed Stobart's arrival in an emailed statement Friday.
'We look forward to working with Dr. Stobart on a new chapter for CancerCare, including on recommendations to strengthen support for cancer specialists so they are best positioned to deliver exceptional care to their patients.'– Doctors Manitoba statement via email
'We look forward to working with Dr. Stobart on a new chapter for CancerCare, including on recommendations to strengthen support for cancer specialists so they are best positioned to deliver exceptional care to their patients,' it said.
Like Chipman, the organization thanked Turner for her temporary leadership.
Doctors Manitoba has been critical of CancerCare and previously called for an independent investigation into operations after a months-long review revealed allegations of burnout, heavy workloads, recruitment challenges, lacklustre communication, favouritism and distrust in the executive leaders.
Nurses and allied health workers came forward with similar allegations after the results of the review became public.
Stobart will assume leadership of CancerCare as the agency prepares to create a new research and treatment facility that could cost up to $1 billion.
The new building will stand next to CancerCare headquarters at 675 McDermot Ave. Construction is slated to begin next August and will continue for about four years, Premier Wab Kinew said in June.
Chipman's letter noted CancerCare planned to publicly announce Stobart as the agency's new leader sometime after Aug. 26, after the provincial byelection in Spruce Woods. Manitoba legislation restricts government departments from making announcements about programs or activities during election periods.
'We look forward to sharing this good news more broadly later this month,' Chipman's letter said.
tyler.searle@freepress.mb.ca
Tyler SearleReporter
Tyler Searle is a multimedia producer who writes for the Free Press's city desk. A graduate of Red River College Polytechnic's creative communications program, he wrote for the Stonewall Teulon Tribune, Selkirk Record and Express Weekly News before joining the paper in 2022. Read more about Tyler.
Every piece of reporting Tyler produces is reviewed by an editing team before it is posted online or published in print — part of the Free Press's tradition, since 1872, of producing reliable independent journalism. Read more about Free Press's history and mandate, and learn how our newsroom operates.
Our newsroom depends on a growing audience of readers to power our journalism. If you are not a paid reader, please consider becoming a subscriber.
Our newsroom depends on its audience of readers to power our journalism. Thank you for your support.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Recall alert: Stop putting your baby in these nests and loungers now, warns Health Canada
Recall alert: Stop putting your baby in these nests and loungers now, warns Health Canada

Ottawa Citizen

timean hour ago

  • Ottawa Citizen

Recall alert: Stop putting your baby in these nests and loungers now, warns Health Canada

Article content Health Canada has recalled a wide range of portable beds for infants because they pose a risk of smothering, entrapment or falls. Article content The products known as baby nests or loungers have soft, padded sides and are advertised as multi-functional products that can be used as a sleep surface, changing mat and tummy time mat. Article content Article content Article content Article content Article content Anyone with one of the above products should immediately stop using it. Health Canada said no nest or lounger is safe for sleep because of a suffocation risk, and no infant should be left unattended in one. Article content The products should never be placed inside another device like a crib, cradle, bassinet or playpen. Nor should they go on a bed, waterbed, air mattress, couch, futon or armchair, because the suffocation risk is greater on soft, uneven surfaces. Article content Even if you bought a baby nest or lounger not listed in the recall, 'Health Canada advises that it not be used as a sleep surface,' said the notice. 'Consumers are reminded that the safest place for a baby to sleep is alone on a firm, flat surface.' Article content Article content Article content Though Health Canada is not aware of any injuries related to the products in Canada, there have been 'continued incidents and concerns related to baby nests/loungers across North America,' and is reminding consumers that the products pose a risk. Article content Article content In the U.S. between 2021 and 2023, the U.S. Consumer Product Safety Commission received 45 reports of incidents involving baby nests and loungers, 29 of which resulted in deaths. Article content Health Canada is currently sampling and evaluating all baby nests and loungers to determine their safety. Meanwhile, the listed brands have been recalled and removed from market because they don't meet Canadian safety standards. Article content

Health Canada recalling several baby loungers, warns of suffocation risks
Health Canada recalling several baby loungers, warns of suffocation risks

CBC

time2 hours ago

  • CBC

Health Canada recalling several baby loungers, warns of suffocation risks

Health Canada is recalling seven baby loungers, saying "continued incidents and concerns" have also prompted it to warn of the overall risks the products pose to infants. "The safest place for a baby to sleep is on their back, alone in a crib, cradle or bassinet that meets current Canadian safety regulations," the department said in a news release, announcing that it is conducting a sampling and evaluation program for the products. As part of the program, Health Canada has so far identified a number of baby nests and loungers that it is recalling and removing from the market, as they do not meet Canadian safety regulations. They include the brands BChic and Chicure, FFQRLP Brand, HAPDEN Travel Portable Crib, Housbay, La Millou, Style Life Eleven, Zoomie Kids and Vevor. The products are available on online marketplaces, such as Amazon, Walmart, AliExpress, Wayfair and Vevor. They are being recalled for a number of hazard risks, including strangulation, choking, entrapment and falling.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store